HOME >> BIOLOGY >> NEWS
Merck / AAAS announce 2005 winners for outstanding undergraduate research programs

WASHINGTON, DC- The Merck Company Foundation and the American Association for the Advancement of Science (AAAS) today announced winners of the 2005 awards for the Merck/AAAS Undergraduate Science Research Program.

This year's winners are Bowdoin College, Fairleigh Dickinson University, Furman University, Harvey Mudd College, Hope College, McNeese State University, North Central College, Northern Kentucky University, Oakland University, Otterbein College, Seattle University, St. Olaf College, University of the Sciences in Philadelphia, Ursinus College, and Vassar College.

The Merck/AAAS Undergraduate Science Research Program (USRP) is a national competitive awards program available in all 50 states, the District of Columbia, and Puerto Rico. Fifteen awards are made annually, and each award provides up to $60,000, paid over three years at $20,000 per year, for joint use by the biology and chemistry departments at each recipient institution. The funding supports research stipends for undergraduate students and ancillary programs that foster interactions between these departments.

Launched in 2000 as a national competition, awards will be made through 2009. This ten-year, $9 million initiative is funded by The Merck Company Foundation and administered by AAAS. The program goals are to:

  • enhance undergraduate education through research experiences that emphasize the interrelationship between chemistry and biology;
  • encourage students to pursue graduate education in chemistry and life sciences; and
  • foster undergraduate programs and activities that bridge chemistry and biology.

The program is open to qualified institutions in the United States and Puerto Rico that offer an American Chemical Society-certified program in chemistry and confer 10 or fewer graduate degrees annually in biology and chemistry combined. For additional information, send questions to merck@aaas.org
'"/>


17-Feb-2005


Page: 1 2

Related biology news :

1. Merck and AAAS announce 2007 winners of Outstanding Undergraduate Research Programs
2. Harvard Medical signs agreement with Merck to develop potential therapy for macular degeneration
3. Merck and AAAS announce 2006 winners for Outstanding Undergraduate Research Programs
4. Researchers gain support from Merck Sharp & Dohme for novel area of diabetes research
5. Nobel Laureate Sydney Brenner receives 2005 UCSD/Merck Life Science Achievement Award
6. Merck CEO Raymond Gilmartin to lecture at NJIT
7. Protein tyrosine phosphatases to be topic of ASBMB-Merck Award lecture
8. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
9. ESA announces 2007 award recipients
10. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
11. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
Breaking Biology Technology:
Cached News: